What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

LAA Closure for Atrial Fibrillation using Occlusion Device

Congenital and Structural Interventions

H. Sievert

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: Fact, Fict…

Houston Methodist DeBakey Heart and Vascular Center

R. Passman

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Watchman Implantation: Tips and Tricks

Innovations in Cardiac Rhythm Management

S. Doshi

START: Stroke Prevention Through AFib Recognition and Treatment

The France Foundation

K. Newlin, L. Vanbrocklin

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

ACC 2023 Conference Coverage

B. Olshansky

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

The Valve Trials Are Done: Interventional HFpEF Is the Next Big Thing

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

Management of Device Detected AF

Taya Glotzer